Filtros de búsqueda

Lista de obras de

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

artículo científico publicado en 2017

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts

artículo científico publicado en 2019

Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation

artículo científico publicado en 2020

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

artículo científico publicado en 2016

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

scientific article published on 18 November 2019

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

artículo científico publicado en 2015

Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

artículo científico publicado en 2020

Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel

artículo científico publicado en 2020

Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma

artículo científico publicado en 2019

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda